MODAGIN
Live / Registered — Registered (as of 24 Dec 2024)
What this means for you
Registered since 24 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97828693
- Registration number
- 7617828
- Mark type
- Stylized text
- Filed
- 08 Mar 2023
- Published for opposition
- 22 Oct 2024
- Registered
- 24 Dec 2024
- Attorney of record
- Ralph G. Fischer
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human medical purposes in the nature of pharmaceutical preparations for the use in the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicines for veterinary purposes for treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical purposes; Injectable pharmaceuticals for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicinal preparations and substances for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Agents against Parkinson's disease, namely, pharmaceutical agents for the treatment of Parkinson's disease; Pharmaceutical medicines in the nature of pharmaceutical preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical products for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical preparations for human use for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of cerebral disease; Pharmaceutical preparations for the treatment of central nervous system diseases
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research in the field of pharmaceuticals; Medical research laboratory services; Conducting technical tests on pharmaceuticals; Conducting analysis of human serum for medical research; Conducting analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research relating to pharmaceuticals; Research and development in the field of pharmacy and biotechnology; Clinical research in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Quality testing for pharmaceutical products; Scientific research in the field of pharmacy; Scientific research and development
- Class 044 — Medical, beauty and agricultural services: Medication counseling; Providing information to patients in the field of administering medications; Providing medical information relating to pharmaceutical products; Providing information relating to the treatment of degenerative diseases; Providing information relating to medical services; Medical advisory services relating to degenerative diseases; Medical consultancy and medical information services relating to pharmaceutical products; Medical consultancy and medical information services relating to pharmaceutical products provided via the Internet; Medical consultancy and medical information services relating to medical products; Medical consultancy services relating to medicines; Medical services; Medical services for the treatment of Alzheimer's disease; Pharmaceutical compounding services; Preparation and administration of medicines being medical services
Owner
- MODAG GmbH, Wendelsheim, DE
- MODAG GmbH, Wendelsheim, DE
- MODAG GmbH, Wendelsheim, DE
Prosecution history
- 24 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION
- 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Aug 2024 — ASSIGNED TO LIE
- 25 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Dec 2023 — NON-FINAL ACTION E-MAILED